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Résumé en
anglais
We evaluated celiprolol-induced vasodilatation in aorta taken from 12-week-old
spontaneously hypertensive rats (SHR) and the effect of AT(1) angiotensin II receptor
antagonism on the vasodilatory action of celiprolol in Wistar Kyoto (WKY) rats and
SHR. In WKY rats, the celiprolol-induced relaxation was greatly decreased in
denuded aorta, and completely abolished in intact aorta by Nω-nitro-l-arginine methyl
ester (⌊-NAME, 100 microM). In SHR, celiprolol-induced relaxation was reduced
compared to WKY rats (Emax (value obtained for the highest concentration, 300
µM)=39.1+ or - 3.78%, n=21 vs. 80.4 + or - 3% in WKY rats, n=10; P<0.0001).
Endothelium removal or pre-treatment with ⌊-NAME did not alter celiprolol-induced
relaxation in SHR. In both strains, relaxation to celiprolol was decreased in the
presence of nadolol (a β1/β2-adrenoceptor antagonist, 10 µM). N-[[3-[(2S)-2-
hydroxy-3-[[2-[4-[(phenylsulfonyl)amino] phenyl]ethyl]amino]
propoxy]phenyl]methyl]-acetamide (L748337, a β3-adrenoceptor antagonist, 7 µM)
had no effect. A 12-day treatment with candesartan cilexetil (an AT(1) receptor
antagonist, 0.37 or 1mg/kg/day) reduced systolic blood pressure in both strains, but
only improved relaxation to celiprolol in SHR, and only at the highest dose
(Emax=64.2+/-3.9%, n=10, P<0.0001 vs. SHR control). In both strains, local aortic AT1
receptor antagonism with candesartan CV11974 (100 µM) had no effect. The
endothelial β1/β2 relaxation induced by celiprolol was therefore impaired in SHR
aorta and AT1receptor antagonism improved the response to celiprolol, in
conjunction with a reduction in blood pressure. This work highlights the need to
analyse the potential benefit of a combination of celiprolol/AT1 receptor antagonist in
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